This month: The role of fatty acids in sex determination; a probe to monitor and inhibit EBNA1 at the same time; a biological role for post-biotics; what happens when you mix microbes, hosts, and drugs; and an antibiotic that cross-protects with acid.
Principles
Fat metabolism has been linked to fertility and reproductive adaptation in animals and humans, but the molecular mechanisms involved in the response of animals' reproductive systems to lipid level changes, including the role of lipids in environmental sex-determination (ESD), are poorly understood. Using Caenorhabditis elegans as a model system, we discovered that fatty acids (FAs) regulate germline sex determination through modulating protein myristoylation (Tang et al., 2017 , Cell 169, 457-469, https://dx.doi.org/10.1016 /j.cell.2017 . This likely represents a conserved mechanism underlying nutrient-dependent ESD.
After observing an impact of FA synthesis and mobilization on oocyte fate, we identified ACS-4, an acyl-CoA synthetase, and its myristoyl-CoA product as key germline factors that mediate the role of FAs in driving oocyte fate through protein myristoylation. We showed that ACS-4-dependent protein myristoylation perceives and translates FA levels into the activities of MAPK and key factors in the germline sex-determination pathway.
''ACS-4-dependent protein myristoylation perceives and translates FA levels into the activities of MAPK and key factors in the germline sexdetermination pathway.''

What's Next?
The big open question that we plan to address is whether this mechanism is conserved in mammals, as we suspect, and what are the key factors regulating mammalian nutrient-dependent ESD. We would also like to investigate the roles of protein lipidation in regulating other developmental events in response to nutrient availability and what other mechanisms are involved in animals' responses to lipid availability. Finally, we are interested in investigating mechanisms underlying ESD by other cues, such as temperature. 
Principles
Epstein-Barr virus (EBV) infects the vast majority of humans worldwide and establishes lifelong persistence in the hosts. EBV presence in the host has been linked to several kinds of malignancies and lymphoproliferative disorders. EBV encoded nuclear antigen 1 (EBNA1) is one of the crucial proteins for the maintenance of the EBV viral genome and an attractive and practical target for the anti-viral therapies. We recently described a direct and sensitive system to track and regulate the nuclear EBNA1 (Jiang et al., 2017, Nat. Biomed. Eng. 1, 0042, https://dx.doi.org/10.1038/s41551-017-0042). Our approach combines a nucleus-permeable EBNA1-specific peptide with an intramolecular charge transfer (ICT) fluorophore to yield a dual-probe, L 2 P 4 , that allows simultaneous visualization and inhibition of EBNA1. We employ luminescence titration to validate selective and strong binding of L 2 P 4 to the wild-type EBNA1 protein. We next show that L 2 P 4 interferes with EBNA1 dimerization and that it suppresses cellular growth, possibly through disrupting the EBNA1 dimer formation.
''L 2 P 4 visualized and regulated nuclear EBNA1 both in vitro and in vivo.''
What's next?
It is well established that zinc coordination regulates EBNA1, which led us to explore whether we can map the intracellular zinc ions in EBVinfected cells and enhance L 2 P 4 therapeutic efficacy by adding a strong zinc binder into the system.
A Post-Biotic Era?
Jonathan Schertzer, McMaster University
Principles
Intestinal dysbiosis during obesity has prompted testing of pre-biotics and pro-biotics in metabolic diseases. ''Post-biotics,'' such as metabolites and components from live or dead bacteria, can also influence host metabolism. It is known that bacterial detection can increase metabolic tissue inflammation and insulin resistance. Alternatively, we hypothesized that bacterial immune evasion or tolerance strategies improve host metabolism. We found a bacterial cell wall post-biotic that lowered metabolic tissue inflammation, restored insulin action, and reduced blood glucose in obese mice (Cavallari et al., Cell Metab. 25, 1063 -1074 ''We found a bacterial cell wall post-biotic that lowered metabolic tissue inflammation, restored insulin action, and reduced blood glucose in obese mice.'' Our data suggest a balancing act between the immune tolerance and pro-inflammatory actions of specific bacterial components and blood glucose control. MDP-based post-biotics countered insulin resistance caused by lipopolysaccharide. Conversely, Nod1-activating muropeptides worsened insulin resistance. A transcriptional program dictated by interferon regulatory factor-4 (Irf4) lies at the cross-roads of how different post-biotics alter insulin and glucose. Irf4 only propagated insulin sensitizing effects of MDP.
What's Next?
Mining the actions of microbiota-derived components and immune circuits that influence endocrine-control of host metabolism may yield new approaches to obesity-related diseases separate from changes in microbial taxonomy. 
Principles
While it is becoming increasingly clear that the microbes inhabiting our bodies can affect how drugs work, the complexity of mammalian models, as well as the lack of tools to systematically explore host-microbe-drug interactions, have made mechanistic insights difficult. We developed a high-throughput screening method using a dual genetically tractable animal-microbe holobiont model to demonstrate that microbes alter the efficacy of the widely used anticancer drug 5-fluorouracil (5-FU) (Scott et al., Cell, 169, 442-456, https://dx.doi. org/10.1016 /j.cell.2017 . To define with precision the microbial contribution to 5-FU action on the host, C. elegans were fed 4,000 different single gene knockout E. coli mutants at a plethora of drug concentrations, allowing us to identify vitamins B6 and B9 and particularly nucleotide metabolism as the key contributors. We show that bacteria metabolically complement the host in converting 5-FU to downstream fluoronucleotides and amplify autophagy-induced cellular death, leading to tumor reduction and cancer survival.
''.bacteria metabolically complement the host.''
What's Next?
This 3-way screening method can be used for exploring many aspects of microbial manipulation of host-targeted drugs and may provide mechanistic insight and predictive power in drug responsiveness. We are currently using the technique to identify other drugs whose effects are microbially modulated, looking at a wider range of bacteria, including those from the mammalian microbiome. This puts us one step closer to personalized medicine.
Antibiotic Protects from Acid
Tobias Bollenbach, University of Cologne and IST Austria
Principles
Antibiotics trigger complex gene expression changes, but it is largely unknown if these responses actually increase bacterial survival. The underlying molecular mechanisms are also poorly understood. Combining measurements of genome-wide transcriptional dynamics, the pH sensor pHluorin, and singlecell time-lapse microscopy in microfluidic devices, we found that the antibiotic trimethoprim triggers a strong transient acid stress response in Escherichia coli bacteria (Mitosch et al., Cell Sys. 4, (393) (394) (395) (396) (397) (398) (399) (400) (401) (402) (403) https ://dx.doi.org/10.1016/j. cels.2017.03.001). As a result, bacteria showed greatly increased survival in a subsequent acidic environment.
The survival of individual cells appeared random at first but turned out to be predictable from the expression level of acid stress genes, which varied drastically from cell-to-cell: cells with higher expression levels survived longer and maintained better intracellular pH homeostasis. How does trimethoprim, which is not an acid, trigger an acid stress response? We found that this antibiotic causes a rapid intracellular pH drop due to the depletion of adenine nucleotides. The cross-protection effect between trimethoprim and acid thus appears to be a consequence of inevitable biochemical events.
''The cross-protection effect between trimethoprim and acid thus appears to be a consequence of inevitable biochemical events.''
It will be interesting to explore if cross-protection is relevant in vivo: here, trimethoprim treatment could protect bacteria from immune cells like macrophages that expose bacteria to an acidic environment in the phagosome. Testing additional cross-protection and -sensitization effects between antibiotics and other stressors predicted by our study may expose new vulnerabilities that could be exploited in treatments.
